MENU
Merus (MRUS) Ownership - Who owns Merus?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.44B
P/E Ratio
N/A
Total Cash
787.42M
Projected Growth
N/A
Total Debt
11.02M
Revenue
35.19M
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash/Share
11.54
Total Debt/Equity
N/A
Revenue/Share
0.61 USD as % of share price
Fundamentals
MRUS
Capitalization
3.44B
P/E Ratio
N/A
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash
787M
Total Cash/Share
11.54
Total Debt
11M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.61%
Revenue
35.2M
ROE
N/A
Book Value
747M
P/B Ratio
4.60
Cash Flow
N/A
Earnings
-2.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.86M
Current Ratio
9.97
Current Revenue Per Employee
32017.47
Dividends Per Share - Security
N/A
EBITDA
-194.57M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-26.70
Shares Held By Institutions
5.41B
Shares Outstanding - Current
68.2M
Total Liabilities
145M
Total Volume MTD
N/A
Value
N/A
Gain YTD
83.164
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for cancer treatment
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl